Serina Therapeutics, Inc.: 10-Q filed 2025-11-13
What Serina Therapeutics, Inc. reported in its quarterly report filed 2025-11-13 (fiscal Q3 2025): 42 published measures, 129 facts as tagged in accession 0001708599-25-000133.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2025-11-13
- Fiscal period
- fiscal Q3 2025
- Accession
- 0001708599-25-000133 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Serina Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 12,413,000 | USD | |
| At 2024-12-31 | 6,724,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 10,819,000 | USD | |
| At 2024-12-31 | 6,216,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,760,000 | USD | |
| At 2024-12-31 | 641,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 8,620,000 | USD | |
| At 2024-12-31 | 3,672,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -4,585,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -15,846,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 1,410,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -8,401,000 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -11,922,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -12,548,000 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 59,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 17,000 | USD | 274 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 0 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 130,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 14,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 70,000 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 16,931,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 8,181,000 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | -59,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -17,000 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | -60,164,000 | USD | |
| At 2024-12-31 | -44,318,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 10,339,000 | shares | 92 |
| 2025-01-01 to 2025-09-30 | 10,032,000 | shares | 273 |
| 2024-07-01 to 2024-09-30 | 8,851,000 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 6,774,000 | shares | 274 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 10,339,000 | shares | 92 |
| 2025-01-01 to 2025-09-30 | 10,032,000 | shares | 273 |
| 2024-07-01 to 2024-09-30 | 10,751,000 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 6,774,000 | shares | 274 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -0.45 | USD/shares | 92 |
| 2025-01-01 to 2025-09-30 | -1.6 | USD/shares | 273 |
| 2024-07-01 to 2024-09-30 | 0.16 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -1.24 | USD/shares | 274 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -0.45 | USD/shares | 92 |
| 2025-01-01 to 2025-09-30 | -1.6 | USD/shares | 273 |
| 2024-07-01 to 2024-09-30 | 0.13 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -1.24 | USD/shares | 274 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 580,000 | USD | |
| At 2024-12-31 | 501,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -6,392,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -17,815,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | -5,312,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -11,499,000 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 11,497,000 | USD | |
| At 2024-12-31 | 5,676,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 8,789,000 | USD | |
| At 2024-12-31 | 2,366,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 2,731,000 | USD | |
| At 2024-12-31 | 744,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 6,392,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 17,945,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 5,326,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 11,569,000 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 3,651,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 9,754,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 2,415,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 5,115,000 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 10,543,000 | shares | |
| At 2024-12-31 | 9,422,000 | shares | |
| At 2024-03-26 | 8,413,889 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 56,987,000 | USD | |
| At 2024-12-31 | 44,958,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | -4,000 | USD | |
| At 2024-12-31 | 0 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,594,000 | USD | |
| At 2025-06-30 | 1,646,000 | USD | |
| At 2025-03-31 | 1,559,000 | USD | |
| At 2024-12-31 | 508,000 | USD | |
| At 2024-09-30 | -13,828,000 | USD | |
| At 2024-06-30 | -16,393,000 | USD | |
| At 2024-03-31 | -28,388,000 | USD | |
| At 2023-12-31 | -32,294,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 312,000 | USD | |
| At 2024-12-31 | 461,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 311,000 | USD | |
| At 2024-12-31 | 460,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,230,000 | USD | |
| At 2024-12-31 | 1,102,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 650,000 | USD | |
| At 2024-12-31 | 601,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 1,144,000 | USD | |
| At 2024-12-31 | 1,429,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2025-09-30 | 2,877,000 | USD | |
| At 2024-12-31 | 2,004,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -4,595,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -15,879,000 | USD | 273 |
| 2025-04-01 to 2025-06-30 | -6,462,000 | USD | 91 |
| 2025-01-01 to 2025-03-31 | -4,822,000 | USD | 90 |
| 2024-07-01 to 2024-09-30 | 1,383,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -8,455,000 | USD | 274 |
| 2024-04-01 to 2024-06-30 | 5,177,000 | USD | 91 |
| 2024-01-01 to 2024-03-31 | -15,015,000 | USD | 91 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -4,589,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -15,850,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 1,410,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -8,401,000 | USD | 274 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | -4,686,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | -16,063,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 1,410,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -8,401,000 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 2,741,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 8,191,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 2,911,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 6,454,000 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 0 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 0 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 0 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 0 | USD | 274 |
Nonoperating interest expense
Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 6,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 15,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 16,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 509,000 | USD | 274 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 35,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 151,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 42,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 185,000 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-07-01 to 2025-09-30 | 1,797,000 | USD | 92 |
| 2025-01-01 to 2025-09-30 | 1,936,000 | USD | 273 |
| 2024-07-01 to 2024-09-30 | 6,695,000 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 3,044,000 | USD | 274 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 155,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | 166,000 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2025-01-01 to 2025-09-30 | 2,008,000 | USD | 273 |
| 2024-01-01 to 2024-09-30 | -712,000 | USD | 274 |
Inspect the source
- Entity
- Serina Therapeutics, Inc. / CIK 0001708599
- Captured
- 2026-09-21T17:26:34.443Z
- SEC response SHA-256
0bf2877f0ae23c086a1e0a1838180a13fde4d4f9e8b48e7e5486890aa9dadc58
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001708599.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))